Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743001828> ?p ?o ?g. }
- W2743001828 endingPage "e0182123" @default.
- W2743001828 startingPage "e0182123" @default.
- W2743001828 abstract "Background and objective Studies investigating the impact of white matter hyperintensities (WMHs) on the response of acetylcholinesterase inhibitors in patients with Alzheimer’s disease (AD) have presented inconsistent results. We aimed to compare the effects of the rivastigmine patch between patients with AD with minimal WMHs and those with moderate WMHs. Methods Three hundred patients with mild to moderate AD were enrolled in this multicenter prospective open-label study and divided into two groups. Group 1 comprised patients with AD with minimal WMHs and group 2 comprised those with moderate WMHs. The patients were treated with a rivastigmine patch for 24 weeks. Efficacy measures were obtained at baseline and after 24 weeks. The primary endpoint was the change in the AD Assessment Scale-Cognitive subscale (ADAS-Cog) from the baseline to the end of the study. Results Of the 300 patients, there were 206 patients in group 1 and 94 patients in group 2. The intention-to-treat group comprised 198 patients (group 1, n = 136; group 2, n = 46) during the 24-week study period. Demographic factors did not differ between group 1 and group 2. There were no significant differences in change in ADAS-cog between group 1 (-0.62±5.70) and group 2 (-0.23±5.98) after the 24-week rivastigmine patch therapy (p = 0.378). The patients in group 1 had a 0.63-point improvement from baseline on the Frontal Assessment Battery, while group 2 had a 0.16-point decline compared to baseline at the end of the study (p = 0.037). The rates of adverse events (AEs) (42.6 vs. 40.3%) and discontinuation due to AEs (10.3% vs. 4.3%) did not differ between the groups. Conclusions Although the efficacy and tolerability of rivastigmine patch therapy were not associated with WMH severity in patients with AD, some improvement in frontal function was observed in those with minimal WMHs. Trial registration ClinicalTrials.gov NCT01380288" @default.
- W2743001828 created "2017-08-17" @default.
- W2743001828 creator A5001679413 @default.
- W2743001828 creator A5002790890 @default.
- W2743001828 creator A5002798749 @default.
- W2743001828 creator A5003588537 @default.
- W2743001828 creator A5005388349 @default.
- W2743001828 creator A5009556695 @default.
- W2743001828 creator A5009819102 @default.
- W2743001828 creator A5013293945 @default.
- W2743001828 creator A5018027454 @default.
- W2743001828 creator A5022338359 @default.
- W2743001828 creator A5031125070 @default.
- W2743001828 creator A5033030009 @default.
- W2743001828 creator A5037529958 @default.
- W2743001828 creator A5049758684 @default.
- W2743001828 creator A5061956113 @default.
- W2743001828 creator A5062304322 @default.
- W2743001828 creator A5067240605 @default.
- W2743001828 creator A5069341668 @default.
- W2743001828 creator A5071062424 @default.
- W2743001828 creator A5081007211 @default.
- W2743001828 creator A5083363274 @default.
- W2743001828 creator A5086373541 @default.
- W2743001828 date "2017-08-07" @default.
- W2743001828 modified "2023-10-15" @default.
- W2743001828 title "Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer’s dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial" @default.
- W2743001828 cites W1511972530 @default.
- W2743001828 cites W1967963591 @default.
- W2743001828 cites W1974225635 @default.
- W2743001828 cites W1977427195 @default.
- W2743001828 cites W1978073725 @default.
- W2743001828 cites W1980827933 @default.
- W2743001828 cites W1982064952 @default.
- W2743001828 cites W1984590366 @default.
- W2743001828 cites W1985528178 @default.
- W2743001828 cites W1995637924 @default.
- W2743001828 cites W1996776294 @default.
- W2743001828 cites W2003672912 @default.
- W2743001828 cites W2007476293 @default.
- W2743001828 cites W2008559862 @default.
- W2743001828 cites W2016526240 @default.
- W2743001828 cites W2025774809 @default.
- W2743001828 cites W2026047746 @default.
- W2743001828 cites W2028378378 @default.
- W2743001828 cites W2034943295 @default.
- W2743001828 cites W2035006594 @default.
- W2743001828 cites W2041523804 @default.
- W2743001828 cites W2045836468 @default.
- W2743001828 cites W2051134431 @default.
- W2743001828 cites W2052011640 @default.
- W2743001828 cites W2057679568 @default.
- W2743001828 cites W2078380966 @default.
- W2743001828 cites W2083711255 @default.
- W2743001828 cites W2086899923 @default.
- W2743001828 cites W2087605208 @default.
- W2743001828 cites W2102099746 @default.
- W2743001828 cites W2107388590 @default.
- W2743001828 cites W2108474398 @default.
- W2743001828 cites W2111958870 @default.
- W2743001828 cites W2117134611 @default.
- W2743001828 cites W2119062449 @default.
- W2743001828 cites W2129913615 @default.
- W2743001828 cites W2130900065 @default.
- W2743001828 cites W2137599726 @default.
- W2743001828 cites W2143879671 @default.
- W2743001828 cites W2150693120 @default.
- W2743001828 cites W2156220037 @default.
- W2743001828 cites W2162252402 @default.
- W2743001828 cites W2168160214 @default.
- W2743001828 cites W2177193267 @default.
- W2743001828 cites W2184923050 @default.
- W2743001828 cites W2193764494 @default.
- W2743001828 cites W2229813864 @default.
- W2743001828 cites W2402684904 @default.
- W2743001828 doi "https://doi.org/10.1371/journal.pone.0182123" @default.
- W2743001828 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5546604" @default.
- W2743001828 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28786987" @default.
- W2743001828 hasPublicationYear "2017" @default.
- W2743001828 type Work @default.
- W2743001828 sameAs 2743001828 @default.
- W2743001828 citedByCount "10" @default.
- W2743001828 countsByYear W27430018282018 @default.
- W2743001828 countsByYear W27430018282021 @default.
- W2743001828 countsByYear W27430018282022 @default.
- W2743001828 countsByYear W27430018282023 @default.
- W2743001828 crossrefType "journal-article" @default.
- W2743001828 hasAuthorship W2743001828A5001679413 @default.
- W2743001828 hasAuthorship W2743001828A5002790890 @default.
- W2743001828 hasAuthorship W2743001828A5002798749 @default.
- W2743001828 hasAuthorship W2743001828A5003588537 @default.
- W2743001828 hasAuthorship W2743001828A5005388349 @default.
- W2743001828 hasAuthorship W2743001828A5009556695 @default.
- W2743001828 hasAuthorship W2743001828A5009819102 @default.
- W2743001828 hasAuthorship W2743001828A5013293945 @default.
- W2743001828 hasAuthorship W2743001828A5018027454 @default.
- W2743001828 hasAuthorship W2743001828A5022338359 @default.
- W2743001828 hasAuthorship W2743001828A5031125070 @default.